Annexin A2 (AnxA2) association with the clinicopathological data in different breast cancer subtypes: A possible role for AnxA2 in tumor heterogeneity and cancer progression
- 15 September 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 308, 120967
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Expression characteristics and diagnostic value of annexin A2 in hepatocellular carcinomaWorld Journal of Gastroenterology, 2012
- The expression of annexin II and its role in the fibrinolytic activity in acute promyelocytic leukemiaLeukemia Research, 2011
- The Role of Annexin A2 in Tumorigenesis and Cancer ProgressionCancer Microenvironment, 2011
- The annexin A2 system and vascular homeostasisVascular Pharmacology, 2011
- Quality indicators in breast cancer careEuropean Journal of Cancer, 2010
- Ki-67 as a prognostic marker according to breast cancer subtype and a predictor of recurrence time in primary breast cancerExperimental and Therapeutic Medicine, 2010
- Knockdown of annexin 2 decreases migration of human glioma cells in vitroNeuropathology and Applied Neurobiology, 2006
- The role of aromatase inhibitors as adjuvant therapy for early breast cancer in postmenopausal womenEuropean Journal of Cancer, 2005
- Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort studyBMJ, 2004
- Breast cancer classification and prognosis based on gene expression profiles from a population-based studyProceedings of the National Academy of Sciences, 2003